Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Merck Stock News

MKGAFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$125.45

-16.36-11.54%

At close: -

$144.39

18.9415.10%

After Hours: Mar 11, 4:01 PM EDT

Merck (MKGAF) Forecast

News

Earnings Merck (MKGAF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Merck Stock News | OTC:MKGAF | Benzinga

Get the latest news on Merck stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Merck performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Sunday, February 16, 2025

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Lekha Gupta - Feb 16, 2025, 9:45AM

Tuesday, February 11, 2025

Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Vandana Singh - Feb 11, 2025, 11:41AM

Monday, January 13, 2025

GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Vandana Singh - Jan 13, 2025, 10:34AM

Monday, June 24, 2024

CORRECTION: Merck KGaA Ticker Is "MKGAF"
Benzinga Newsdesk - Jun 24, 2024, 1:06PM
'Merck KGaA: Phase III trials of xevinapant i...
Benzinga Newsdesk - Jun 24, 2024, 1:04PM

Wednesday, December 06, 2023

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Vandana Singh - Dec 6, 2023, 8:48AM

Tuesday, December 05, 2023

Germany's Merck KGaA Says Results From EVOLUT...
Benzinga Newsdesk - Dec 5, 2023, 5:52PM

Tuesday, September 26, 2023

Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Vandana Singh - Sep 26, 2023, 3:07PM

Thursday, August 03, 2023

Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Vandana Singh - Aug 3, 2023, 11:27AM

Wednesday, July 26, 2023

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Vandana Singh - Jul 26, 2023, 10:24AM

Friday, June 30, 2023

Watching Abcam; Co Seeing Takeover Interest From Danaher, Agilent Technologies, Germany's Merck KGaA
Happy Mohamed - Jun 30, 2023, 12:26PM

Tuesday, June 20, 2023

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Vandana Singh - Jun 20, 2023, 2:37PM

Wednesday, May 17, 2023

Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Vandana Singh - May 17, 2023, 9:17AM

Tuesday, April 18, 2023

Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Vandana Singh - Apr 18, 2023, 7:20AM

Wednesday, April 12, 2023

FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Vandana Singh - Apr 12, 2023, 10:12AM

Monday, March 27, 2023

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Vandana Singh - Mar 27, 2023, 1:23PM

Thursday, March 23, 2023

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Vandana Singh - Mar 23, 2023, 7:39AM

Tuesday, January 03, 2023

PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Vandana Singh - Jan 3, 2023, 11:13AM

Friday, December 23, 2022

Mersana Inks Cancer Therapy Development Deal With Merck Germany
Vandana Singh - Dec 23, 2022, 10:08AM

Thursday, September 30, 2021

GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Vandana Singh - Sep 30, 2021, 3:27PM

Tuesday, September 21, 2021

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Vandana Singh - Sep 21, 2021, 11:02AM

Tuesday, August 24, 2021

Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Vandana Singh - Aug 24, 2021, 7:47AM

Tuesday, June 01, 2021

Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
Vandana Singh - Jun 1, 2021, 2:02PM
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
Vandana Singh - Jun 1, 2021, 9:05AM
Immutep Announced New Collaboration with Merck KGaA, Darmstadt, Germany for LAG-3 Therapy, Efti
Charles Gross - Jun 1, 2021, 5:09AM

Friday, May 14, 2021

Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share
Vandana Singh - May 14, 2021, 3:40PM

Monday, May 10, 2021

UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer
Vandana Singh - May 10, 2021, 2:48PM

Tuesday, April 20, 2021

Palantir Deepens Relationship With Ringier To Help It Transform Into A Digital-First, Global Media Company
Shanthi Rexaline - Apr 20, 2021, 1:45PM

Wednesday, April 07, 2021

Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio
Vandana Singh - Apr 7, 2021, 7:08AM

Thursday, March 18, 2021

Exelixis' XL092 To Be Tested In Combination With Bavencio In Urothelial Carcinoma
Vandana Singh - Mar 18, 2021, 9:10AM

Wednesday, March 17, 2021

Germany's Merck Invests In French Facility For Single Use Products
Vandana Singh - Mar 17, 2021, 2:24PM

Monday, January 25, 2021

Pfizer Announced EC Approved BAVENCIO for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Charles Gross - Jan 25, 2021, 5:43AM

Thursday, January 14, 2021

Philips, Merck KGaA Partner to Develop Personalized Fertility Treatment Solutions
Charles Gross - Jan 14, 2021, 5:48AM

Tuesday, November 24, 2020

The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
Shanthi Rexaline - Nov 24, 2020, 8:12AM

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights - Mar 24, 2020, 11:35AM

Friday, January 10, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Jan 10, 2020, 12:18PM

Thursday, January 09, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Jan 9, 2020, 3:15PM

Monday, June 15, 2015

EU Approves Merck Acquisition of Sigma-Aldric...
Benzinga - Jun 15, 2015, 1:31PM

Wednesday, May 27, 2015

Merck Offers Concessions in Effort to Get EU ...
Benzinga - May 27, 2015, 7:55AM

Tuesday, May 19, 2015

Merck KGAA CFO Says EU has Limited Concerns R...
Benzinga - May 19, 2015, 4:37AM

Wednesday, August 07, 2013

Opexa Shares Rise Almost 200% on Positive Cha...
Benzinga - Aug 7, 2013, 9:57AM

Monday, January 31, 2011

Teva Expands in Latin America - Analyst Blog
Benzinga - Jan 31, 2011, 11:45AM

Wednesday, January 26, 2011

CHMP Stands Negative on MKGAF Drug - Analyst Blog
Benzinga - Jan 26, 2011, 8:15AM

Thursday, January 06, 2011

Teva Expands Women's Health Biz - Analyst Blog
Benzinga - Jan 6, 2011, 8:45AM

Wednesday, December 29, 2010

MKGAF Sells Agricultural Business - Analyst Blog
Benzinga - Dec 29, 2010, 12:15PM

Monday, December 20, 2010

Sanofi Expands Oncology Pipeline - Analyst Blog
Benzinga - Dec 20, 2010, 1:36PM

Monday, November 29, 2010

Merck KGaA MS Drug Faces Glitch - Analyst Blog
Benzinga - Nov 29, 2010, 10:18AM

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved